
VESTAL POINT CAPITAL, LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | VYGR | 1.48M | $6.89M |
![]() | ACLX | 1.25M | $102.63M |
![]() | GMED | 1.25M | $71.59M |
![]() | CLDX | 1.21M | $31.17M |
![]() | DNTH | 1.18M | $46.43M |
![]() | ELVN | 1.16M | $23.75M |
![]() | NYXH | 1.11M | $5.09M |
![]() | ALC | 1.10M | $81.96M |
![]() | NUVL | 1.10M | $95.13M |
![]() | XENE | 1.10M | $44.16M |
![]() | IONS | 1.07M | $70.33M |
![]() | ABVX | 1.00M | $84.90M |
![]() | ALEC | 980K | $2.90M |
![]() | RAPP | 950K | $28.21M |
![]() | ANRO | 950K | $3.82M |
![]() | BMRN | 830K | $44.95M |
![]() | LUNG | 830K | $1.34M |
![]() | GLUE | 800K | $5.93M |
![]() | VERA | 760K | $22.09M |
![]() | RARE | 750K | $22.56M |

Voyager Therapeutics, Inc.
VYGR
Shares Held
1.48M
Value
$6.89M

Arcellx, Inc.
ACLX
Shares Held
1.25M
Value
$102.63M

Globus Medical, Inc.
GMED
Shares Held
1.25M
Value
$71.59M

Celldex Therapeutics, Inc.
CLDX
Shares Held
1.21M
Value
$31.17M

Dianthus Therapeutics, Inc.
DNTH
Shares Held
1.18M
Value
$46.43M

Enliven Therapeutics, Inc.
ELVN
Shares Held
1.16M
Value
$23.75M

Nyxoah S.A.
NYXH
Shares Held
1.11M
Value
$5.09M

Alcon Inc.
ALC
Shares Held
1.10M
Value
$81.96M

Nuvalent, Inc.
NUVL
Shares Held
1.10M
Value
$95.13M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
1.10M
Value
$44.16M

Ionis Pharmaceuticals, Inc.
IONS
Shares Held
1.07M
Value
$70.33M

Abivax S.A.
ABVX
Shares Held
1.00M
Value
$84.90M

Alector, Inc.
ALEC
Shares Held
980K
Value
$2.90M

Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
950K
Value
$28.21M

Alto Neuroscience, Inc.
ANRO
Shares Held
950K
Value
$3.82M

BioMarin Pharmaceutical Inc.
BMRN
Shares Held
830K
Value
$44.95M

Pulmonx Corporation
LUNG
Shares Held
830K
Value
$1.34M

Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
800K
Value
$5.93M

Vera Therapeutics, Inc.
VERA
Shares Held
760K
Value
$22.09M

Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
750K
Value
$22.56M
